New pill combo aims to ease arthritis pain in 60 days
NCT ID NCT07549386
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a daily capsule combining etoricoxib and diacerein can reduce pain and improve function in adults with knee or hip osteoarthritis. Over 60 days, 123 participants took either the test combination or an active comparator (meloxicam plus diacerein). Researchers measured pain changes using a standard scale and tracked side effects to compare safety and effectiveness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
etoricoxib and diacerein combination
What this could lead to
If successful, this could offer a new pain relief option for people with knee or hip osteoarthritis.
What could go wrong
This is a completed Phase 3 trial, but results are not yet published. The combination may not prove more effective or safer than existing treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ainpad, S.C.
Morelia, Michoacán, 58350, Mexico
-
Grupo Médico ASSET, S.C.
Mexico City, Mexico City, 03100, Mexico
-
Hospital Centro Quirúrgico Nogalar, S.A. de C.V.
Monterrey, Nuevo León, 66484, Mexico
-
RM Pharma Specialists S.A. de C.V.
Mexico City, Mexico City, 03100, Mexico